Log in
Enquire now
‌

US Patent 9464071 Pyrazolyl quinoxaline kinase inhibitors

Patent 9464071 was granted and assigned to Astex Therapeutics Limited on October, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
‌
Astex Therapeutics Limited
0
Date Filed
October 2, 2014
0
Date of Patent
October 11, 2016
0
Patent Applicant
‌
Astex Therapeutics Limited
0
Patent Application Number
14505020
0
Patent Citations Received
‌
US Patent 11918576 Combination of an FGFR inhibitor and a CMET inhibitor
0
‌
US Patent 11684620 Pharmaceutical compositions comprising N-(3,5-dimethoxyphenyl)-N′-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
0
Patent Inventor Names
Gilbert Ebai Besong
0
Tom Cornelis Hortense Govaerts
0
Valerio Berdini
0
Werner Constant Johan Embrechts
0
Alexandra Papanikos
0
Berthold Wroblowski
0
Christopher Charles Frederick Hamlett
0
Christopher Norbert Johnson
0
Christopher William Murray
0
David Charles Rees
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9464071
0
Patent Primary Examiner
‌
Jeffrey S Lundgren
0

Find more entities like US Patent 9464071 Pyrazolyl quinoxaline kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.